Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-14 Purchase | 2024-02-15 4:21 pm | Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director | 2,000 | $11 | $22,000 | 2,000 (Direct) | View |
| 2022-04-01 Purchase | 2022-04-04 4:15 pm | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 10,000 | $0.7474 | $7,474 | 52,081 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-24 Disposition | 2024-01-24 5:27 pm | N/A 2029-01-15 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 2,332,541 | $0 | 0 (Direct) | View |
| 2023-10-05 Option Award | 2023-10-10 5:39 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 20,000 | $0 | 35,000 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:28 pm | N/A 2033-05-09 | Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director | 8,300 | $0 | 8,300 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-14 08:30 am | N/A 2032-05-31 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 20,000 | $0 | 427,081 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-14 08:30 am | N/A N/A | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 20,000 | $0.4591 | 427,081 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 6:00 pm | N/A 2033-02-28 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 585,000 | $0 | 585,000 (Direct) | View |
| 2023-02-09 Exercise | 2023-02-13 08:09 am | N/A 2032-05-31 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 20,000 | $0 | 427,081 (Direct) | View |
| 2023-02-09 Exercise | 2023-02-13 08:09 am | N/A N/A | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 20,000 | $0.4591 | 427,081 (Direct) | View |
| 2022-10-04 Option Award | 2022-10-06 6:11 pm | N/A 2028-02-06 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 1,930,956 | $0 | 1,930,956 (Direct) | View |
| 2022-10-04 Disposition | 2022-10-06 6:11 pm | N/A 2028-02-06 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 1,398,145 | $0 | 1,930,956 (Direct) | View |
| 2022-09-15 Option Award | 2022-09-19 5:40 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 08:00 am | N/A 2032-05-31 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 375,000 | $0 | 375,000 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-12 8:26 pm | N/A 2032-05-10 | Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director | 8,300 | $0 | 8,300 (Direct) | View |
| 2022-01-05 Option Award | 2022-01-07 5:09 pm | N/A 2032-01-05 | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 2,214 | $9.03 | 2,214 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-18 4:55 pm | N/A 2031-08-17 | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-17 5:04 pm | N/A 2031-05-12 | Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director | 8,300 | $0 | 8,300 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 5:00 pm | N/A 2031-01-31 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 337,731 | $0 | 337,731 (Direct) | View |
| 2021-01-29 Exercise | 2021-02-01 4:15 pm | N/A 2028-02-06 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 10,000 | $0 | 468,266 (Direct) | View |
| 2021-01-29 Exercise | 2021-02-01 4:15 pm | N/A N/A | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 10,000 | $2.44 | 468,266 (Direct) | View |
| 2021-01-08 Option Award | 2021-01-12 4:49 pm | N/A N/A | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 10,667 | $0 | 32,081 (Direct) | View |
| 2021-01-11 Tax Withholding | 2021-01-12 4:49 pm | N/A N/A | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 3,706 | $6.72 | 32,081 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:28 pm | N/A 2031-01-04 | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 1,314 | $13.31 | 1,314 (Direct) | View |
| 2020-10-27 Option Award | 2020-10-27 5:37 pm | N/A 2030-10-27 | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-09-29 Option Award | 2020-09-30 1:52 pm | N/A 2030-07-16 | Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director | 16,600 | $0 | 16,600 (Direct) | View |
| 2020-06-11 Exercise | 2020-06-15 5:03 pm | N/A 2028-02-06 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 10,000 | $0 | 461,305 (Direct) | View |
| 2020-06-11 Exercise | 2020-06-15 5:03 pm | N/A N/A | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 10,000 | $2.44 | 461,305 (Direct) | View |
| 2020-04-01 Option Award | 2020-04-03 4:26 pm | N/A 2030-03-31 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 7:09 pm | N/A 2030-01-02 | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 2,704 | $6.47 | 2,704 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 4:24 pm | N/A 2030-01-01 | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 200,000 | $0 | 200,000 (Direct) | View |
Ownership | 2020-01-02 4:19 pm | N/A N/A | Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks | 0 | $0 | 745,534 (Direct) | View |
| 2019-06-26 Option Award | 2019-06-27 7:36 pm | N/A 2029-06-26 | ZAFGEN INC. | ZFGN | THOMAS FRANK E Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2019-06-05 Option Award | 2019-06-05 6:50 pm | N/A 2029-06-05 | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 6,073 | $0 | 6,073 (Direct) | View |